Organisation paid for research Program year 2023 Source: CMS Open Payments

Valkyrie Clinical Trials, Inc.

Neither a doctor nor a teaching hospital

Research payments

$227,928

13 payments

Through program year 2023, Valkyrie Clinical Trials, Inc. is reported as receiving $227,928 in research payments, across 13 payments.

By program year

3 rows
Year Kind Amount Payments
2023 Research $28,330 3
2022 Research $184,098 9
2021 Research $15,500 1

Breakdown

Who paid Research payments · program years 2021–2023
  1. Karyopharm Therapeutics Inc. $227,928 13 payments
Studies the money was for Research payments · program years 2021–2023
  1. A Phase 2 Open-Label Multicenter Study to Evaluate the Safety and Efficacy of Selinexor With Or Without Pembrolizumab Versus Standard of Care in Previously Treated Metastatic Colorectal Cancer With Ras Mutations $227,928 13 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record